PGEN Stock Analysis: Buy, Sell, or Hold?
PGEN - Precigen, Inc. Common Stock
$4.42
-0.18 (-3.91%)
▼
5d:
+4.99%
30d:
+11.9%
90d:
-10.34%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Distribution
PGEN is up 5.0% this week, but smart money is buying puts. Top strike: $3 2026-07-17 with 15,070 OI. Put ratio: 68% View Scanner →
Strength: 4.3/10
Get Alerted When PGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called PGEN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PGEN is fairly valued with market pricing in 2.3% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: PGEN is fairly valued with market pricing in 2.3% annual growth. Fine to hold or accumulate slowly on dips.
In-depth Analysis How we analyze
Valuation Analysis: PGEN is currently trading at $4.42, which is considered extended relative to its 30-day fair value range of $3.98 to $4.29. The stock's valuation (Forward PE: 80.4) is in line with its historical norms (75.0). At these levels, the market is pricing in 2.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $4.02, while resistance sits at $4.87. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: PGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.50 (+114.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGEN is in a strong uptrend. Immediate support is located at $4.02, while resistance sits at $4.87. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: PGEN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.50 (+114.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.98 -
$4.29
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding PGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BULLISH: Trading 114.9% below Wall St target ($9.50)
- NEUTRAL: Market pricing in 2.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$3.98 -
$4.29
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.02
Resistance Level
$4.87
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
80.36
Wall Street Target
$9.50
(+114.9%)
Revenue Growth (YoY)
283.6%
Valuation Premium vs History
+2.3% premium
PE vs Historical
80.4 vs 75.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.3%
(market-implied from PE analysis)
1-Year Target
$4.52
(+2%)
2-Year Target
$4.63
(+5%)
3-Year Target
$4.73
(+7%)
3-Yr Target (if PE normalizes)
(PE: 80→75)
PE COMPRESSION
$4.42
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 18, 2026 7:29 AM ET
Data refreshes hourly during market hours. Next update: 8:29 AM
Data refreshes hourly during market hours. Next update: 8:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Randal J Kirk
SELL
4772781 shares
2026-03-30
Randal J Kirk
SELL
1900036 shares
2025-12-22
Randal J Kirk
SELL
937308 shares
2025-11-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$103 | 55 HOLD |
Advanced PGEN Option Strategies
Professional options setups generated by AI based on today's PGEN price and gamma walls.
